Researcher Profile

Lucia Masarova

🏛 Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

0000-0001-6624-4196

Publications

Citations

Co-Authors

Active Years

Publications

Journal Article The Lancet Haematology Nov 01, 2025

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study

Ruben Mesa · Harinder Gill · Lei Zhang · Jie Jin +30 more

10.1016/s2352-3026(25)00264-9 3 citations

Journal Article Clinical Cancer Research Aug 16, 2023

Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies

Jayastu Senapati · Warren C. Fiskus · Naval Daver · Nathaniel R. Wilson +20 more

10.1158/1078-0432.ccr-23-1429 22 citations

Open Access Journal Article JACC: Cardiovascular Imaging May 01, 2021

Decreased Global Strains of LV in Asymptomatic Female Duchenne Muscular Dystrophy Gene Carriers Using CMR-FT

Lucia Masarova · Mary Luz Mojica-Pisciotti · Roman Panovsky · Vladimír Kincl +7 more

10.1016/j.jcmg.2020.09.016 5 citations

Journal Article Clinical Infectious Diseases Apr 01, 2020

Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study

Prithviraj Bose · David McCue · Sebastian Wurster · Nathan P Wiederhold +19 more

10.1093/cid/ciaa358 63 citations

Publication Timeline

2025

2023

2021

2020

Frequent Co-Authors

2×

2×

2×

2×

2×

2×

2×

1×

1×

1×